RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 144 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,937 | -33.0% | 906,767 | -34.6% | 0.25% | -30.8% |
| Q2 2023 | $10,353 | +11.8% | 1,385,950 | 0.0% | 0.36% | -10.2% |
| Q1 2023 | $9,259 | -99.9% | 1,385,950 | 0.0% | 0.40% | -24.2% |
| Q4 2022 | $10,685,675 | -27.5% | 1,385,950 | 0.0% | 0.53% | -36.7% |
| Q3 2022 | $14,747,000 | +561.9% | 1,385,950 | +406.5% | 0.84% | +419.3% |
| Q2 2022 | $2,228,000 | +13.7% | 273,650 | 0.0% | 0.16% | +89.4% |
| Q1 2022 | $1,959,000 | -56.0% | 273,650 | +5.3% | 0.08% | -47.2% |
| Q4 2021 | $4,453,000 | -25.5% | 259,941 | 0.0% | 0.16% | -17.0% |
| Q3 2021 | $5,981,000 | – | 259,941 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Obvious Management Services, L.L.C. | 3,985,087 | $42,401,000 | 100.00% |
| Two Sigma Ventures, LP | 903,400 | $9,612,000 | 100.00% |
| DCVC Opportunity Fund II GP, LLC | 3,951,141 | $42,040,000 | 54.37% |
| Data Collective IV GP, LLC | 5,941,120 | $63,214,000 | 49.97% |
| MIC Capital Management UK LLP | 8,451,758 | $89,927,000 | 16.21% |
| MV Management XI, L.L.C. | 1,971,908 | $20,981,000 | 15.20% |
| ArchPoint Investors | 1,116,126 | $11,876,000 | 4.85% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $16,058,000 | 2.00% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,251,971 | $23,961,000 | 1.00% |
| Duquesne Family Office | 1,385,950 | $14,747,000 | 0.84% |